autologous tumor cell vaccine
Term · Oncology and biomedicine · MLC-T-ONC-011786
A therapeutic agent produced by isolating tumor cells from an individual and processing these tumor cells into a vaccine formulation in vitro; the vaccine is then administered to the individual from whom the tumor cells were isolated. Typically combined with an adjuvant immunostimulant, an autologous cell vaccine may elicit a cytotoxic T-lymphocytic immune response to cell surface-expressed tumor-associated antigens (TAAs), resulting in tumor cell death.
| Identifier | MLC-T-ONC-011786 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | ATCV |
| Synonyms | Autologous Cell Vaccine; AC vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011786",
"term": "autologous tumor cell vaccine",
"field": "Oncology and biomedicine",
"definition": "A therapeutic agent produced by isolating tumor cells from an individual and processing these tumor cells into a vaccine formulation in vitro; the vaccine is then administered to the individual from whom the tumor cells were isolated. Typically combined with an adjuvant immunostimulant, an autologous cell vaccine may elicit a cytotoxic T-lymphocytic immune response to cell surface-expressed tumor-associated antigens (TAAs), resulting in tumor cell death.",
"abbreviation": "ATCV",
"synonyms": [
"Autologous Cell Vaccine",
"AC vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-tumor-cell-vaccine/"
}
Record 3,124 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.